BS, Anthropology/Music, Brandeis University, Undergraduate - 1978

M.D., Medicine, Pennsylvania State University College of Medicine, Graduate - 1982

The New York Hospital - Internship - 1983 - 1983

The New York Hospital - Residency - 1984 - 1985

Pediatric Cardiology, Children’s Hospital, Boston - Fellowship - 1985 - 1988

Pediatric Cardiology

Pediatrics

Division of Pediatric Cardiology, Department of  Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA

Director of Program Development, The Cardiac Center, Children’s Hospital of Philadelphia

Senior Physician, Division of Critical Care Medicine, Department of Anesthesia and Critical Care Medicine, Children’s Hospital of Philadelphia

Medical Director, Cardiac Intensive Care Unit, Children’s Hospital of Philadelphia

Pediatric Cardiac Intensive Care Society – Founding Member and Board of Directors; 1999-present

Steering Committee, World Congress of Pediatric Cardiology and Cardiac Surgery; 2002-present

Medical Advisory Board, The Children’s Health Information Network, 1998-Present

Dr. Wernovsky is the Director of Program Development at The Cardiac Center at The Children's Hospital of Philadelphia, and the Medical Director of the Cardiac Intensive Care Unit. Dr. Wernovsky’s clinical interests are primarily in inpatient care; particularly of newborns and infants with critical congenital heart disease. He has been an invited lecturer and visiting professor throughout the world, has co-edited four textbooks, and published nearly 200 chapters and articles in peer-reviewed journals.

For the past 20 years, he has been especially interested in the long-term functional outcomes following surgery for critical heart disease, particularly transposition of the great arteries, and forms of single ventricle such as hypoplastic left heart syndrome. From 1986-1987, he was a study physician in the Second Natural History Study (NHS-2) sponsored by the NIH. Between 1987 and 1992, he conducted the pilot study and was one of the study physicians for the “Boston Circulatory Arrest Trial”, one of the largest randomized clinical trials in congenital heart disease. While in Boston, he cared for and published extensively about a group of nearly 600 patients following the arterial switch operation for transposition of the great arteries, and was the principal investigator of a cross sectional study of the survivors of the first 500 Fontan operations performed at Boston Children’s Hospital. Since his appointment in Philadelphia, he was the co-editor of the first textbook dedicated exclusively to the care and outcomes of children with hypoplastic left heart syndrome, as well as a textbook on pediatric heart failure. He served as the chair of the steering committee and principal investigator of the recently completed PRIMACORP trial: a multi-center trial aimed at the prevention of low cardiac output after cardiac surgery, one of the largest multi-center trial in the field of cardiac intensive care. He is currently a member of the Neurocardiac Research Group at The Children's Hospital of Philadelphia, which is prospectively evaluating a cohort of over 400 children with all forms of complex congenital heart disease.

He is a founding member and on the Organizing Committee of the Pediatric Cardiac Intensive Care Society, and is a member of the Steering Committee of the World Congress of Pediatric Cardiology and Cardiac Surgery. In the American College of Cardiology, he was an elected member of the Congenital Heart Disease and Pediatric Cardiology Committee. In the Council on Cardiovascular Disease in the Young of the American Heart Association, he was chair of the Communications Committee from 1999-2001, and an elected member of the executive committee from 1996-2001.